• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Anticoagulation therapy in non-valvular atrial fibrillation in the COVID-19 era: is it time to reconsider our therapeutic strategy?

作者信息

Papakonstantinou Panteleimon E, Borovac Josip A, Gąsecka Aleksandra, Bongiovanni Dario, Ehrlinder Hanne, Giustozzi Michela, Parker William A E, Guerreiro Rui Azevedo

机构信息

Second Cardiology Department, Evangelismos Hospital, Ipsilantou 45-47, 106 76 Athens, Greece.

Hypertension Unit "ESH Excellence Centre", First Cardiology Clinic, Medical School, National and Kapodistrian University of Athens, Hippokration Hospital, Athens, Greece.

出版信息

Eur J Prev Cardiol. 2022 Nov 8;29(15):2069-2071. doi: 10.1093/eurjpc/zwab021.

DOI:10.1093/eurjpc/zwab021
PMID:33564838
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7928961/
Abstract
摘要

相似文献

1
Anticoagulation therapy in non-valvular atrial fibrillation in the COVID-19 era: is it time to reconsider our therapeutic strategy?新冠疫情时代非瓣膜性心房颤动的抗凝治疗：是时候重新审视我们的治疗策略了吗？
Eur J Prev Cardiol. 2022 Nov 8;29(15):2069-2071. doi: 10.1093/eurjpc/zwab021.
2
Atrial fibrillation, diabetes and anticoagulation with direct oral anticoagulants: time to reconsider duration of the disease to evaluate the bleeding risk?心房颤动、糖尿病和直接口服抗凝剂抗凝：是否需要重新考虑疾病持续时间以评估出血风险？
Acta Cardiol. 2021 Jul;76(5):461-463. doi: 10.1080/00015385.2020.1870194. Epub 2021 Jan 13.
3
Anticoagulation and atrial fibrillation. Putting the results of clinical trials into practice.抗凝与心房颤动。将临床试验结果应用于实践。
West J Med. 1995 Aug;163(2):145-52.
4
Apixaban versus Antiplatelet drugs or no antithrombotic drugs after anticoagulation-associated intraCerebral HaEmorrhage in patients with Atrial Fibrillation (APACHE-AF): study protocol for a randomised controlled trial.阿哌沙班与抗血小板药物或房颤患者抗凝相关脑出血后不使用抗血栓药物对比研究（APACHE-AF）：一项随机对照试验的研究方案
Trials. 2015 Sep 4;16:393. doi: 10.1186/s13063-015-0898-4.
5
Evaluation of the impact of warfarin time in therapeutic range on outcomes of patients with atrial fibrillation in Turkey: perspectives from the observational, prospective WATER Registry.评估华法林在治疗范围内的时间对土耳其心房颤动患者结局的影响：来自观察性前瞻性WATER注册研究的观点
Cardiol J. 2015;22(5):567-75. doi: 10.5603/CJ.a2015.0035. Epub 2015 Jun 23.
6
Stroke Prevention in Atrial Fibrillation: The Role of Oral Anticoagulation.心房颤动的卒中预防：口服抗凝的作用。
Med Clin North Am. 2019 Sep;103(5):847-862. doi: 10.1016/j.mcna.2019.05.006.
7
Periprocedural Outcomes of Direct Oral Anticoagulants Versus Warfarin in Nonvalvular Atrial Fibrillation.直接口服抗凝剂与华法林在非瓣膜性心房颤动中的围手术期结局。
Circulation. 2018 Oct 2;138(14):1402-1411. doi: 10.1161/CIRCULATIONAHA.117.031457.
8
Anticoagulation for stroke prevention in elderly patients with non-valvular atrial fibrillation: what are the obstacles?老年非瓣膜性心房颤动患者预防卒中的抗凝治疗：障碍有哪些？
Hong Kong Med J. 2016 Dec;22(6):608-15. doi: 10.12809/hkmj154803.
9
Oral anticoagulants usage in Japanese patients aged 18-74 years with non-valvular atrial fibrillation: a retrospective analysis based on insurance claims data.基于保险理赔数据的 18-74 岁非瓣膜性心房颤动日本患者的口服抗凝药物使用情况：一项回顾性分析。
Fam Pract. 2019 Nov 18;36(6):685-692. doi: 10.1093/fampra/cmz016.
10
Anticoagulation therapy for patients with non-valvular atrial fibrillation: comparison of decision analytic model recommendations and real-world warfarin prescription use.非瓣膜性心房颤动患者的抗凝治疗：决策分析模型建议与真实世界华法林处方使用的比较。
Am J Cardiovasc Drugs. 2012 Oct 1;12(5):313-23. doi: 10.1007/BF03261840.

引用本文的文献

1
EASY OR NOT. European-Asian Six countries Yearly consensus On Recent guidelines: arterial hypertension, atrial fibrillation, chronic coronary syndromes, and peripheral artery diseases. Novel Or conventional Treatment options for these patients. Position Paper 2024.易与否。欧亚六国关于近期指南的年度共识：动脉高血压、心房颤动、慢性冠状动脉综合征和外周动脉疾病。这些患者的新型或传统治疗选择。2024年立场文件
Cardiol J. 2025;32(3):213-227. doi: 10.5603/cj.105140. Epub 2025 May 13.
2
Influence of the COVID-19 pandemic on patients receiving oral anticoagulants for the treatment of non-valvular atrial fibrillation.2019年冠状病毒病大流行对接受口服抗凝剂治疗非瓣膜性心房颤动患者的影响。
Int J Cardiol Heart Vasc. 2024 Feb 10;51:101358. doi: 10.1016/j.ijcha.2024.101358. eCollection 2024 Apr.
3
A Delphi consensus on the management of anticoagulation in the COVID-19 pandemic: the MONACO study.关于2019冠状病毒病大流行期间抗凝管理的德尔菲共识：摩纳哥研究
Cardiovasc Diagn Ther. 2023 Oct 31;13(5):777-791. doi: 10.21037/cdt-23-76. Epub 2023 Oct 25.
4
Clinical Management of New-Onset Atrial Fibrillation in COVID-19 Patients Referred to a Tertiary Cardiac Arrhythmia Center after Hospital Discharge.出院后转诊至三级心律失常中心的COVID-19患者新发房颤的临床管理
J Clin Med. 2022 Sep 26;11(19):5661. doi: 10.3390/jcm11195661.
5
2021 Focused update of the 2017 consensus guidelines of the Asia Pacific Heart Rhythm Society (APHRS) on stroke prevention in atrial fibrillation.亚太心律学会（APHRS）2017年房颤卒中预防共识指南2021年重点更新。
J Arrhythm. 2021 Nov 13;37(6):1389-1426. doi: 10.1002/joa3.12652. eCollection 2021 Dec.
6
2021 Focused Update Consensus Guidelines of the Asia Pacific Heart Rhythm Society on Stroke Prevention in Atrial Fibrillation: Executive Summary.2021 年亚太心律学会心房颤动卒中预防聚焦更新共识指南：执行摘要。
Thromb Haemost. 2022 Jan;122(1):20-47. doi: 10.1055/s-0041-1739411. Epub 2021 Nov 13.
7
Pharmacotherapy of atrial fibrillation in COVID-19 patients.COVID-19 患者心房颤动的药物治疗。
Cardiol J. 2021;28(5):758-766. doi: 10.5603/CJ.a2021.0088. Epub 2021 Aug 12.

本文引用的文献

1
Switching warfarin patients to a direct oral anticoagulant during the Coronavirus Disease-19 pandemic.在2019冠状病毒病大流行期间将华法林患者转换为直接口服抗凝剂。
Thromb Res. 2021 Jan;197:192-194. doi: 10.1016/j.thromres.2020.11.004. Epub 2020 Nov 7.
2
The Prognostic Value of Electrocardiogram at Presentation to Emergency Department in Patients With COVID-19.心电图在 COVID-19 患者急诊科就诊时的预后价值。
Mayo Clin Proc. 2020 Oct;95(10):2099-2109. doi: 10.1016/j.mayocp.2020.07.028. Epub 2020 Aug 15.
3
Evaluation of Remote Pharmacist-Led Outpatient Service for Geriatric Patients on Rivaroxaban for Nonvalvular Atrial Fibrillation During the COVID-19 Pandemic.COVID-19大流行期间，针对使用利伐沙班治疗非瓣膜性心房颤动的老年患者开展远程药师主导门诊服务的评估
Front Pharmacol. 2020 Aug 21;11:1275. doi: 10.3389/fphar.2020.01275. eCollection 2020.
4
Atrial Arrhythmias in COVID-19 Patients.新冠病毒感染患者的房性心律失常
JACC Clin Electrophysiol. 2020 Sep;6(9):1189-1190. doi: 10.1016/j.jacep.2020.05.015. Epub 2020 May 28.
5
2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): The Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC.2020年欧洲心脏病学会（ESC）与欧洲心胸外科学会（EACTS）合作制定的心房颤动诊断和管理指南：欧洲心脏病学会（ESC）心房颤动诊断和管理特别工作组，由ESC欧洲心律协会（EHRA）特别贡献制定。
Eur Heart J. 2021 Feb 1;42(5):373-498. doi: 10.1093/eurheartj/ehaa612.
6
Preliminary Experience With Low Molecular Weight Heparin Strategy in COVID-19 Patients.新型冠状病毒肺炎患者低分子量肝素策略的初步经验
Front Pharmacol. 2020 Aug 6;11:1124. doi: 10.3389/fphar.2020.01124. eCollection 2020.
7
Recommendations on antithrombotic treatment during the COVID-19 pandemic. Position statement of the Working Group on Cardiovascular Thrombosis of the Spanish Society of Cardiology.2019冠状病毒病大流行期间抗栓治疗的建议。西班牙心脏病学会心血管血栓形成工作组立场声明
Rev Esp Cardiol (Engl Ed). 2020 Sep;73(9):749-757. doi: 10.1016/j.rec.2020.04.025. Epub 2020 Jun 19.
8
The tug-of-war between coagulopathy and anticoagulant agents in patients with COVID-19.新型冠状病毒肺炎患者凝血功能障碍与抗凝药物之间的较量。
Eur Heart J Cardiovasc Pharmacother. 2020 Jul 1;6(4):262-264. doi: 10.1093/ehjcvp/pvaa048.
9
Cost-effectiveness of rivaroxaban plus aspirin (dual pathway inhibition) for prevention of ischaemic events in patients with cardiovascular disease: on top optimisation of secondary prevention medication in the context of COVID-19 pandemia.利伐沙班联合阿司匹林（双途径抑制）预防心血管疾病患者缺血性事件的成本效益：在2019冠状病毒病大流行背景下优化二级预防用药之上
Eur J Prev Cardiol. 2020 Sep;27(13):1351-1353. doi: 10.1177/2047487320920754. Epub 2020 Apr 17.
10
Survey of Antithrombotic Treatment in Rural Patients (>60 years) with Atrial Fibrillation in East China.华东地区农村 >60 岁房颤患者抗栓治疗调查。
Sci Rep. 2018 May 1;8(1):6830. doi: 10.1038/s41598-018-24878-y.